Plain-English translation of NCT07371572 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 3 — Testing in thousands of people, comparing the treatment against what doctors currently use. This is the last big step before approval.
This trial is testing methylprednisolone — a steroid medication — given as an injection into the muscle to see if it can relieve hand pain caused by osteoarthritis. Researchers want to find the best dose by comparing a higher dose, a lower dose, and a placebo (a dummy injection with no active medication) to see which works best. The study will follow participants for up to 48 weeks to understand how well and how safely this treatment works.
Hand osteoarthritis can be very painful and limiting, and many people don't get enough relief from common pain medications like ibuprofen or topical creams. This trial is exploring whether this medication, given as an injection, might offer better pain relief for people who have struggled with standard treatments.
You likely qualify if…
You likely don't qualify if…
You'll visit the hospital several times over 48 weeks. At your first visit, you'll receive an injection (either the higher dose, lower dose, or placebo) and have blood tests, ultrasound imaging, X-rays of your hand, and a physical exam including grip strength testing. Four weeks later, you'll return to see how your pain has improved. From week 16 onward, if your pain returns and meets certain criteria, you can request additional injections (up to two more during this period), and you'll continue to be monitored through week 48 with a final follow-up visit.
AI-generated summary from trial data · Jun 3, 2026 · Not medical advice
Netherlands